Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease ; volume:4 ; number:1 ; day:17 ; month:9 ; year:2016 ; pages:1-20 ; date:12.2016
Acta Neuropathologica Communications ; 4, Heft 1 (17.9.2016), 1-20, 12.2016
- Creator
- Contributor
-
Meldner, Sascha
Rehder, Klara Franziska
Gröne, Hermann-Josef
Nordström, Viola
SpringerLink (Online service)
- DOI
-
10.1186/s40478-016-0354-z
- URN
-
urn:nbn:de:1111-201610187735
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Herzer, Silke
- Meldner, Sascha
- Rehder, Klara Franziska
- Gröne, Hermann-Josef
- Nordström, Viola
- SpringerLink (Online service)
Other Objects (12)
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Identification of key lipid metabolism-related genes in Alzheimer’s disease
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Alzheimer’s Disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
Linking APOE4/4 genotype to microglial lipid droplets and neurotoxicity in Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Identification of key lipid metabolism-related genes in Alzheimer’s disease
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Alzheimer’s Disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
Linking APOE4/4 genotype to microglial lipid droplets and neurotoxicity in Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Identification of key lipid metabolism-related genes in Alzheimer’s disease
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Alzheimer’s Disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen